Cyclophosphamide 500 mg Inj,Inj Cytosine Arabinoside Preservative free 100 mg,Dacarbazine 200mg Inj
Indian Army
PANCHKULA, HARYANA
Bid Publish Date
11-Mar-2025, 12:33 pm
Bid End Date
01-Apr-2025, 1:00 pm
EMD
₹6,426
Location
Progress
RAQuantity
7465
Bid Type
Two Packet Bid
Indian Army invites bids for HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP, E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml, INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX, Rocuronium 10 mg ml 10 ml Vial Inj, Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott, PEGYLATED L ASPARAGINASE 3750 UNITS INJ, Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU, 3rd Generation Recombinant Factor VIII 250 IU Inj in PUNE, MAHARASHTRA. Quantity: 7465. Submission Deadline: 01-04-2025 13: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP , E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml , INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX , Rocuronium 10 mg ml 10 ml Vial Inj , Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott , PEGYLATED L ASPARAGINASE 3750 UNITS INJ , Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU , 3rd Generation Recombinant Factor VIII 250 IU Inj
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
PANCHKULA, HARYANA
Indian Army
Directorate Of Health And Family Welfare Services
CHICKMAGALUR, KARNATAKA
N/a
THANE, MAHARASHTRA
Indian Navy
VISAKHAPATNAM, ANDHRA PRADESH
Tender Results
Loading results...
HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP
HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP
E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml
E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml
INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX
INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX
Rocuronium 10 mg ml 10 ml Vial Inj
Rocuronium 10 mg ml 10 ml Vial Inj
Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott
Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott
PEGYLATED L ASPARAGINASE 3750 UNITS INJ
PEGYLATED L ASPARAGINASE 3750 UNITS INJ
Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU
Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU
3rd Generation Recombinant Factor VIII 250 IU Inj
3rd Generation Recombinant Factor VIII 250 IU Inj
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP | HYDROXY PROPYL METHYL CELLULOSE 0 3 Percentage 3 MG ML SODIUM CHLORIDE BORIC ACID POTASSIUM CHLORIDE AND SODIUM PERBORATE EYE DROP | 2,700 | bott | [email protected] | 30 | |
| 2 | E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml | E D Moxifloxacin 0 5 Dexamethasone 0 1 percentage with sodium phosphate ph 7 8 with LDPE with drop trainer package 5 ml | 1,900 | bott | [email protected] | 30 | |
| 3 | INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX | INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0 5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX | 45 | vial | [email protected] | 30 | |
| 4 | Rocuronium 10 mg ml 10 ml Vial Inj | Rocuronium 10 mg ml 10 ml Vial Inj | 600 | vial | [email protected] | 30 | |
| 5 | Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott | Propan 2 ol 63 0 g equals 72 vol percentage Benzalkonium Chloride 0 025 g Purified Water Sunset Yellow dye 500 ml Bott | 1,800 | bott | [email protected] | 30 | |
| 6 | PEGYLATED L ASPARAGINASE 3750 UNITS INJ | PEGYLATED L ASPARAGINASE 3750 UNITS INJ | 30 | vial | [email protected] | 30 | |
| 7 | Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU | Recombinant Factor VIII Human Plasma Albumin Free Viral Inactivation through solvent detergent treatment step Vial of 500 IU | 300 | vial | [email protected] | 30 | |
| 8 | 3rd Generation Recombinant Factor VIII 250 IU Inj | 3rd Generation Recombinant Factor VIII 250 IU Inj | 90 | vial | [email protected] | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
23-Apr-2025, 3:00 pm
End
24-Apr-2025, 3:50 pm
Duration: 25 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 01-04-2025 12:27:59 | |
| 2 | ********** Under PMA | - | 31-03-2025 18:34:13 | |
| 3 | ********** Under PMA | - | 31-03-2025 19:11:17 | |
| 4 | ********** Under PMA | - | 20-03-2025 19:36:05 | |
| 5 | ********** Under PMA | - | 01-04-2025 12:45:14 | |
| 6 | ********** Under PMA | - | 29-03-2025 17:53:53 | |
| 7 | ********** Under PMA | - | 20-03-2025 17:00:17 | |
| 8 | ********** Under PMA | - | 31-03-2025 21:50:42 | |
| 9 | ********** Under PMA | - | 31-03-2025 17:39:54 | |
| 10 | ********** Under PMA | - | 26-03-2025 12:49:42 | |
| 11 | ********** Under PMA | - | 01-04-2025 12:15:09 | |
| 12 | ********** Under PMA | - | 18-03-2025 17:44:13 |
Key insights about MAHARASHTRA tender market
The eligibility requirements include being a registered entity capable of providing 3rd Generation Recombinant Factor VIII products. Bidders must demonstrate compliance with all regulatory standards for biomedical products. Additional criteria may involve previous experience in supplying similar products and possessing necessary certifications.
The technical specifications for the products require that they be of the latest generation and adhere to strict quality control standards. Each unit must be validated for safety and efficacy, and documentation of viral inactivation through the solvent detergent method is mandatory.
The Earnest Money Deposit (EMD) serves as a financial assurance and demonstrates the bidder’s commitment to fulfilling the tender requirements. The specific amount for the EMD will be outlined in the tender documents, and it must be submitted alongside the bid to qualify for evaluation.
To comply with the submission methods for this tender, documents should be submitted electronically through the official tendering platform. Ensure all required documents are included in the submission, as incomplete submissions may lead to disqualification.
Yes, there are specific provisions for Micro, Small, and Medium Enterprises (MSEs) and startups aimed at encouraging participation. These may include relaxation of some eligibility criteria and preferences in the evaluation process to support the growth of local businesses within the sector. Companies are advised to check specific concessions available in the tender documents.
Indian Army
📍 CENTRAL DELHI, DELHI
Indian Army
Indian Army
📍 JALPAIGURI, WEST BENGAL
Indian Army
📍 JODHPUR, RAJASTHAN
Indian Air Force
📍 JORHAT, ASSAM
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS